Clinitech Laboratory Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 32 as of 07 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 .The P/E Ratio of Global Longlife Hospital and Research Ltd is 0 as of March 2025 . The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 .The Market Cap of Global Longlife Hospital and Research Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution in Ahmedabad.
Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

FAQs for the comparison of Clinitech Laboratory Ltd and Global Longlife Hospital and Research Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Global Longlife Hospital and Research Ltd?

Market cap of Clinitech Laboratory Ltd is 7 Cr while Market cap of Global Longlife Hospital and Research Ltd is 13 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Global Longlife Hospital and Research Ltd?

The stock performance of Clinitech Laboratory Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Global Longlife Hospital and Research Ltd?

As of October 25, 2026, the Clinitech Laboratory Ltd stock price is INR ₹32.0. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹12.57.

How do dividend payouts of Clinitech Laboratory Ltd and Global Longlife Hospital and Research Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.